Calendrier des promotions Genprex, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Genprex, Inc.
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.| IPO date | 2018-03-29 |
|---|---|
| ISIN | US3724461047 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.genprex.com |
| Цена ао | 2.74 |
| Changement de prix par jour: | -1.65% (0.89) |
|---|---|
| Changement de prix par semaine: | -3.81% (0.91) |
| Changement de prix par mois: | -18.95% (1.08) |
| Changement de prix sur 3 mois: | +135.93% (0.371) |
| Changement de prix sur six mois: | -55.57% (1.97) |
| Changement de prix par an: | -90.49% (9.2) |
| Evolution du prix sur 3 ans: | -36.57% (1.38) |
| Evolution du prix sur 5 ans: | +222.75% (0.2712) |
| Evolution des prix sur 10 ans: | 0% (0.8753) |
| Evolution des prix depuis le début de l'année: | -59.29% (2.15) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Vanguard Group Inc | 45665 | 2.39 |
| Advisory Services Network, LLC | 17185 | 0.9 |
| CVI Holdings, LLC | 15456 | 0.81 |
| Geode Capital Management, LLC | 12321 | 0.64 |
| Blackrock Inc. | 11392 | 0.6 |
| Renaissance Technologies, LLC | 8988 | 0.47 |
| Citadel Advisors Llc | 4780 | 0.25 |
| State Street Corporation | 4311 | 0.23 |
| Squarepoint Ops LLC | 2945 | 0.15 |
| Commonwealth Equity Services, LLC | 2683 | 0.14 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. David M. Schloss | Senior Vice President of Human Resources | N/A | |
| Mr. Thomas C. Gallagher Esq. | Senior Vice President of Intellectual Property & Licensing | N/A | |
| Dr. Mark S. Berger M.D. | Chief Medical Officer | 528.16k | 1955 (70 années) |
| Mr. Ryan M. Confer M.S. | President, CEO, CFO & Director | 1982 (43 année) | |
| Dr. Suzanne Thornton-Jones Ph.D. | Senior Vice President of Regulatory Affairs & Quality | ||
| Dr. Jack A. Roth F.A.C.S., M.D. | Chairman of Scientific & Medical Advisory Board |
Adresse: United States, Austin. TX, 3300 Bee Cave Road - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.genprex.com
Site web: https://www.genprex.com
